TLDR Iran has fired over 500 ballistic missiles and 2,000 drones since the conflict began, with low-cost Shahed drones breaking through defenses Six U.S. servicemembersTLDR Iran has fired over 500 ballistic missiles and 2,000 drones since the conflict began, with low-cost Shahed drones breaking through defenses Six U.S. servicemembers

U.S. Drone War Drives Demand for Counter-Drone Stocks Like Ondas and BlackSky

2026/03/07 01:45
3 min di lettura
Per feedback o dubbi su questo contenuto, contattateci all'indirizzo crypto.news@mexc.com.

TLDR

  • Iran has fired over 500 ballistic missiles and 2,000 drones since the conflict began, with low-cost Shahed drones breaking through defenses
  • Six U.S. servicemembers were killed and multiple regional targets hit, including the U.S. Embassy in Saudi Arabia
  • Ondas stock has surged over 1,200% in the past year and just secured $6 million in new counter-drone orders from Middle East customers
  • BlackSky and Iridium are seen as secondary plays, with Oppenheimer rating all three at Outperform
  • Ondas subsidiary Airobotics also holds a $20 million purchase order for an autonomous border protection system

The ongoing air war between the U.S., Israel, and Iran is reshaping demand for counter-drone technology — and a handful of stocks are moving fast as a result.

Iran has fired more than 500 ballistic missiles and over 2,000 drones since the conflict began last Saturday, according to Gen. Dan Caine, chairman of the Joint Chiefs of Staff. While most were intercepted, those that got through caused serious damage.

Six U.S. servicemembers were killed at a base in Kuwait. The U.S. Embassy in Saudi Arabia was struck. Qatar’s main liquified-natural-gas plant was damaged. Iran’s weapon of choice is the low-cost Shahed drone, which can be deployed in large numbers to overwhelm defense systems.

Ondas is one of the companies drawing attention. It makes the Iron Drone interceptor, which can disable multiple types of small drones. Oppenheimer rates the stock Outperform with a $16 price target. The stock rose 4.9% to $10.51 on Wednesday.


ONDS Stock Card
Ondas Holdings Inc., ONDS

On March 6, Ondas announced it had received approximately $6 million in new orders for counter-drone systems from defense and homeland security customers in the Middle East and other regions. The orders cover dozens of Sentrycs Cyber-RF counter-UAS systems.

What the Sentrycs System Does

The Sentrycs system detects, tracks, and takes control of unauthorized drones using protocol manipulation. It can redirect drones away from protected areas or land them in designated zones. The company says it is built for fast deployment alongside existing detection systems.

The company also reported revenue growth of 208% over the last twelve months and holds more cash than debt on its balance sheet. Its market cap stands at $4.72 billion.

BlackSky and Iridium Also in Focus

BlackSky and Iridium are flagged as secondary plays on the drone boom. Both provide satellite and communications technology, which has become important as the air war unfolds in a “highly contested” communications environment across the Gulf region.

BlackSky stock rose 7% to $24.30 on Wednesday. Iridium gained 2.1% to $24.51. Oppenheimer holds Outperform ratings on both, with price targets of $31 and $34 respectively.

Other defense firms with counter-drone exposure include CACI, AeroVironment, Kratos Defense, Lockheed Martin, RTX, and Northrop Grumman — covering everything from jammers to laser systems to smart bullets.

Ondas subsidiary Airobotics holds a separate $20 million purchase order for an autonomous border protection system under a multi-year government contract.

The post U.S. Drone War Drives Demand for Counter-Drone Stocks Like Ondas and BlackSky appeared first on CoinCentral.

Opportunità di mercato
Logo Union
Valore Union (U)
$0.000985
$0.000985$0.000985
-2.08%
USD
Grafico dei prezzi in tempo reale di Union (U)
Disclaimer: gli articoli ripubblicati su questo sito provengono da piattaforme pubbliche e sono forniti esclusivamente a scopo informativo. Non riflettono necessariamente le opinioni di MEXC. Tutti i diritti rimangono agli autori originali. Se ritieni che un contenuto violi i diritti di terze parti, contatta crypto.news@mexc.com per la rimozione. MEXC non fornisce alcuna garanzia in merito all'accuratezza, completezza o tempestività del contenuto e non è responsabile per eventuali azioni intraprese sulla base delle informazioni fornite. Il contenuto non costituisce consulenza finanziaria, legale o professionale di altro tipo, né deve essere considerato una raccomandazione o un'approvazione da parte di MEXC.

Potrebbe anche piacerti

Bio Protocol Raises $6.9M to Advance AI-Powered Decentralized Science

Bio Protocol Raises $6.9M to Advance AI-Powered Decentralized Science

The post Bio Protocol Raises $6.9M to Advance AI-Powered Decentralized Science appeared on BitcoinEthereumNews.com. Decentralized science (DeSci) platform Bio Protocol secured backing from investors including Maelstrom Fund and Animoca Brands to expand its artificial intelligence-native biotech research framework.  Bio Protocol announced Wednesday that it had raised $6.9 million in funding, reflecting growing interest in decentralized approaches to drug discovery that integrate AI, blockchain and community engagement.  Maelstrom founder Arthur Hayes described Bio Protocol as a potential “category-defining launchpad” for scientific research. “If it works, it’s not just a launchpad – it’s the birth of an AI-native research market,” he said. Hayes also highlighted how it opens up research opportunities that communities find appealing, not just what academics find interesting.  Cointelegraph reached out to Maelstrom and Animoca for more information, but did not receive a response by publication.  Source: Bio Protocol Speeding up science using AI and crypto DeSci is a movement that uses blockchain technology, crypto incentives and decentralized governance to change how scientific research is conducted, funded and shared. Bio Protocol said it’s speeding up science by integrating crypto and AI. Its approach compresses the drug discovery pipeline using blockchain-based funding and coordination.  Instead of waiting years for traditional grants to be awarded or pharma partnerships to be formed, researchers can use decentralized AI agents, dubbed “BioAgents” that generate hypotheses, connect to onchain wallets and channel community-raised capital into experiments.  Each step of the process will be recorded onchain, ensuring that contributors will be credited and maintaining an immutable record of research progress.  The protocol also uses crypto-native incentives to keep research moving faster. It uses tokenized intellectual property, staking systems and loyalty rewards to align investors, researchers and community members around shared outcomes.  Related: ‘Science needs an update’: How DeSci can fix junk science and cure baldness Addressing inefficiencies in academic research Simon Dedic, the founder of Moonrock Capital, one of Bio…
Condividi
BitcoinEthereumNews2025/09/19 11:05
Urgent Warning For US Banks To Avoid Payments Market Collapse

Urgent Warning For US Banks To Avoid Payments Market Collapse

The post Urgent Warning For US Banks To Avoid Payments Market Collapse appeared on BitcoinEthereumNews.com. Crypto Regulatory Clarity: Urgent Warning For US Banks
Condividi
BitcoinEthereumNews2026/03/09 12:02
Trump’s Decisive Stance: US Will Consult Israel on Ending Iran War But Retains Final Authority

Trump’s Decisive Stance: US Will Consult Israel on Ending Iran War But Retains Final Authority

BitcoinWorld Trump’s Decisive Stance: US Will Consult Israel on Ending Iran War But Retains Final Authority WASHINGTON, D.C., March 2025 – In a significant statement
Condividi
bitcoinworld2026/03/09 12:40